Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Neutral

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Trevena, Inc. (TRVN)

Pharmaceutical Preparations

https://www.trevena.com

Trevena Inc is an American biopharmaceutical company focused on developing and commercializing novel medicines for patients affected by central nervous system, or CNS, disorders.

955 CHESTERBROOK BOULEVARD, SUITE 110
CHESTERBROOK, PA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

01/31/2014

Market Cap

3,300,851

Shares Outstanding

17,290,000

Weighted SO

17,289,104

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

ACRX --.--%

LPCN --.--%

VSTM --.--%

VTVT --.--%

NBRV --.--%

Beta

1.0510

Last Div

0.0000

Range

3.35-28.0

Chg

0.1000

Avg Vol

43423

Mkt Cap

3300851

Exch

NASDAQ

Country

US

Phone

610 354 8840

DCF Diff

4.2480

DCF

-0.4980

Div Yield

0.0000

P/S

7.4343

EV Multiple

-0.6800

P/FV

-0.1741

Div Yield %

0.0000

P/E

-0.0892

PEG

0.0001

Payout

0.0000

Current Ratio

3.4635

Quick Ratio

3.4635

Cash Ratio

3.1439

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

200.8653

CCC

-200.8653

Gross Margin

-3.6329

Op Margin

-79.6284

Pretax Margin

-83.2838

Net Margin

-83.3536

Eff Tax Rate

-0.0099

ROA

-1.6131

ROE

3.9247

ROCE

-1.9933

NI/EBT

1.0008

EBT/EBIT

1.0459

EBIT/Rev

-79.6284

Debt Ratio

1.4209

D/E

-1.7196

LT Debt/Cap

2.5081

Total Debt/Cap

2.3896

Int Coverage

6.7730

CF/Debt

-0.9667

Equity Multi

-1.2103

Rec Turnover

0.0000

Pay Turnover

1.8171

Inv Turnover

0.0000

FA Turnover

0.1016

Asset Turnover

0.0194

OCF/Share

-36.9569

FCF/Share

-36.9816

Cash/Share

19.1938

OCF/Sales

-70.9775

FCF/OCF

1.0007

CF Coverage

-0.9667

ST Coverage

-29.3974

CapEx Coverage

-1500.6667

Div&CapEx Cov

-1500.6667

P/BV

-0.1741

P/B

-0.1741

P/S

7.4343

P/E

-0.0892

P/FCF

-0.1047

P/OCF

-0.1047

P/CF

-0.1047

PEG

0.0001

P/S

7.4343

EV Multiple

-0.6800

P/FV

-0.1741

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Dec 28, 14:00 Trevena Announces the Closing of $4 Million Concurrent Private Placement and Warrant Exercise GlobeNewswire Inc. Dec 27, 09:10 Trevena Inc. Announces $4 Million Concurrent Private Placement and Warrant Exercise

Revenue Product Segmentation